Sponsors
The bill tightens honey definitions, testing, and enforcement to better protect consumers and honest producers from adulteration, but it imposes compliance costs, administrative burdens, and resource needs that may strain regulators and hurt small or traditional honey producers.
Consumers will be less likely to buy adulterated or misbranded honey because the bill establishes clearer product definitions, requires testing/certification by packers, and strengthens detection/enforcement.
Honest domestic honey producers and small packers gain market clarity and protection from fraudulent competitors, which can help preserve prices and reputation.
FDA and partner agencies will gain coordinated lab capacity and data-sharing tools to detect and remove adulterated honey from commerce more quickly.
Small packers and some producers will face new testing, certification, relabeling and administrative costs that may squeeze margins, drive consolidation, or raise consumer prices.
The new requirements and deadlines could strain FDA and other agencies — diverting staff time to reporting, rulemaking, and enforcement and risking rushed or under-vetted actions.
A strict USP-based definition risks excluding some traditional or regional honey products that do not meet pharmacopeial criteria, harming rural producers and cultural practices.
Based on analysis of 4 sections of legislative text.
Mandates an FDA honey standard of identity, creates a Honey Integrity Program requiring packer testing, reporting, and enforcement to detect honey adulteration.
Introduced March 13, 2025 by Thomas Hawley Tuberville · Last progress March 13, 2025
Requires the FDA to set an official standard of identity for honey within one year and to create a Honey Integrity Program that detects and responds to economically motivated adulteration (EMA) of honey. The bill makes qualifying commercial honey packers responsible for testing honey sold in the U.S., reporting results and EMA findings to FDA and law enforcement, and refusing adulterated product; it also directs FDA to investigate, confirm results, share data with other agencies, and produce a report to Congress within two years on enforcement actions related to adulterated or misbranded honey.